Evidence Based Criteria for the Antidepressant Choice
___
1. IMS Institute. The Use of Medicines in the United States: Review of 2011. 2012 [cited 2017; Available from: http://www. imshealth.com/files/web/IMSH%20Institute/Reports/The%20 Use%20of%20Medicines%20in%20the%20United%20 States%202011/IHII_Medicines_in_U.S_Report_2011.pdf. (access date: 04.03.2017)2. Franchini L, Serretti A, Gasperini M, Smeraldi E. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 1998; 32:255-259. [CrossRef]
3. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Muller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry 2016; 61:540-560. [CrossRef]
4. Fabbri C, Serretti A. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications. Curr Psychiatry Rep 2015; 17:50. [CrossRef]
5. Perlis RH. Abandoning personalization to get to precision in the pharmacotherapy of depression. World Psychiatry 2016; 15:228-235. [CrossRef]
6. Sankar PL, Parker LS. The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genet Med 2016. [Epub ahead of print] [CrossRef]
7. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaanalysis. Lancet 2009; 373:746-758. [CrossRef]
8. Alberti S, Chiesa A, Andrisano C, Serretti A. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol 2015; 35:296-303. [CrossRef]
9. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 2009; 29:259-266. [CrossRef]
10. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010; 71:1259-1272. [CrossRef]
- ISSN: 1018-8681
- Yayın Aralığı: Yılda 4 Sayı
- Başlangıç: 1984
- Yayıncı: Kare Yayıncılık
Serum Apelin And Nesfatin-1 Levels in Depression Patients and Their Relationship with Treatment
Şahap DEDE, Musa ŞAHPOLAT, MEHMET HANİFİ KOKAÇYA, Mustafa ARI, Cem SESLİOKUYUCU, Zafer YÖNDEN
Sentetik kannabinoid kullanımı olan bir olguda pregabalin bağımlılığı
Medroxyprogesterone Acetate-Induced Mania in a Patient with Bipolar Affective Disorder
Memduha AYDIN, Bilge Cetin ILHAN, Abdulbaki AKYİLDİZ, İbrahim EREN
Cüneyt EVREN, Gökhan UMUT, Bilge EVREN
Co-Occurrence of Autism Spectrum Disorder and Very Early Onset Schizophrenia: a Case Report
Duygu KABA, Pinar URAN, Ayla SOYKAN AYSEV
Filiz İZCİ, Ebru FINDIKLI, Serkan ZİNCİR, Akif CAMKURT, Ozlem KİZİLKURT, Ferzan GİYNAS, SEVDA KORKMAZ, Emin Barış AKIN
Gamma-hydroxybutyrate (GHB): an Emerging Substance of Abuse
ÜRÜN ÖZER ÇERİ, Mert BATMAZ, Ibrahim AKBAS
Evidence Based Criteria for the Antidepressant Choice
Yunus HACIMUSALAR, ERTUĞRUL EŞEL